S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
LON:EXPN

Experian (EXPN) Price Target & Analyst Ratings

GBX 2,819
+6.00 (+0.21%)
(As of 05:30 AM ET)
Compare
Today's Range
2,812
2,825
50-Day Range
2,568
2,840
52-Week Range
2,242
3,160
Volume
77,572 shs
Average Volume
1.51 million shs
Market Capitalization
£25.91 billion
P/E Ratio
3,355.95
Dividend Yield
1.56%
Price Target
GBX 2,996.17

Experian Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

GBX 2,935.40
High PredictionGBX 3,250
Average PredictionGBX 2,935.40
Low PredictionGBX 2,500
TypeCurrent
5/22/22 to 5/22/23
1 Month Ago
4/22/22 to 4/22/23
3 Months Ago
2/21/22 to 2/21/23
1 Year Ago
5/22/21 to 5/22/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 2,935.40GBX 2,996.17GBX 2,996.17GBX 3,316
Get Experian Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EXPN and its competitors with MarketBeat's FREE daily newsletter.


EXPN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EXPN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Experian Stock vs. The Competition

TypeExperianIndustrials Companies
Consensus Rating Score
2.33
2.45
Consensus RatingHoldHold
News Sentiment RatingPositive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/19/2023Shore Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
3/13/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral
1/25/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutralGBX 3,250 ➝ GBX 2,900+1.26%
1/18/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderperformGBX 2,500-15.57%
11/29/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight
11/17/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweightGBX 3,250+13.12%
(Data available from 5/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












EXPN Price Target - Frequently Asked Questions

What is Experian's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Experian stock is Hold based on the current 1 sell rating, 2 hold ratings and 3 buy ratings for EXPN. The average twelve-month price prediction for Experian is GBX 2,935.40 with a high price target of GBX 3,250 and a low price target of GBX 2,500. Learn more on EXPN's analyst rating history.

Do Wall Street analysts like Experian more than its competitors?

Analysts like Experian less than other Industrials companies. The consensus rating score for Experian is 2.33 while the average consensus rating score for industrials companies is 2.45. Learn more on how EXPN compares to other companies.

Does Experian's stock price have much upside?

According to analysts, Experian's stock has a predicted upside of 2.52% based on their 12-month price targets.

What analysts cover Experian?

Experian has been rated by Citigroup, and Shore Capital in the past 90 days.


Stock Ratings Reports and Tools

This page (LON:EXPN) was last updated on 5/22/2023 by MarketBeat.com Staff

My Account -